Yıldırım M - Search Results

1

Reoperation does not provide a survival advantage in patients with recurrent Glioblastoma treated with irinotecan/bevacizumab treatment.

Sever ON, Oktay K, Güzel E, Kaya V, Güzel A, Yıldırım M. Sever ON, et al. Among authors: yildirim m. Indian J Cancer. 2021 Jan-Mar;58(1):91-95. doi: 10.4103/ijc.IJC_758_18. Indian J Cancer. 2021. PMID: 33402574 Free article.

2

Prognostic Significance of Indicators of Systemic Inflammatory Responses in Glioblastoma Patients.

Kaya V, Yıldırım M, Yazıcı G, Yalçın AY, Orhan N, Güzel A. Kaya V, et al. Among authors: yildirim m. Asian Pac J Cancer Prev. 2017 Dec 29;18(12):3287-3291. doi: 10.22034/APJCP.2017.18.12.3287. Asian Pac J Cancer Prev. 2017. PMID: 29286221 Free PMC article.

3

Checkpoint inhibitors in advanced nonsmall-cell lung cancer; a Bayesian network meta-analysis.

Bozcuk H, Yıldırım M, Sever Ö, Mutlu H, Artaç M. Bozcuk H, et al. Among authors: yildirim m. J Cancer Res Ther. 2020 Jul-Sep;16(4):828-837. doi: 10.4103/jcrt.JCRT_450_19. J Cancer Res Ther. 2020. PMID: 32930126 Free article.

4

Effectiveness of Platinum-Based Treatment for Triple Negative Metastatic Breast Cancer: a Meta-Analysis.

Kaya V, Yildirim M, Yazici G, Gunduz S, Bozcuk H, Paydas S. Kaya V, et al. Among authors: yildirim m. Asian Pac J Cancer Prev. 2018 May 26;19(5):1169-1173. doi: 10.22034/APJCP.2018.19.5.1169. Asian Pac J Cancer Prev. 2018. PMID: 29801396 Free PMC article. Review.

5

Lung Adenocarcinoma Metastasis Mimicking Peripheral Nerve Sheath Tumor: Case Report and Review of Literature.

Oktay K, Guzel E, Bitiren M, Simsek S, Yildirim M, Guzel A. Oktay K, et al. Among authors: yildirim m. World Neurosurg. 2018 Dec;120:490-494. doi: 10.1016/j.wneu.2018.09.128. Epub 2018 Sep 26. World Neurosurg. 2018. PMID: 30266705 Review.

6

Programmed death-1 or programmed death ligand-1 inhibitors? A meta-analysis of differential efficacy as compared to chemotherapy in advanced non-small cell lung cancer.

Bozcuk H, Artaç M, Mutlu H, Sever Ö, Yıldırım M. Bozcuk H, et al. Among authors: yildirim m. J Oncol Pharm Pract. 2021 Mar;27(2):405-413. doi: 10.1177/1078155220964903. Epub 2020 Oct 12. J Oncol Pharm Pract. 2021. PMID: 33040676 Review.

7

Lack of Any Role of Systemic Inflammatory Responses in Predicting Muscle Invasion by Bladder Cancer.

Solakhan M, Demirpence O, Orhan N, Yildirim OA, Guzel E, Yildirim M. Solakhan M, et al. Among authors: yildirim oa, yildirim m. Asian Pac J Cancer Prev. 2016;17(8):3737-9. Asian Pac J Cancer Prev. 2016. PMID: 27644609 Free article.

8

Prognostic importance of the nutritional status and systemic inflammatory response in non-small cell lung cancer.

Yildirim M, Yildiz M, Duman E, Goktas S, Kaya V. Yildirim M, et al. J BUON. 2013 Jul-Sep;18(3):728-32. J BUON. 2013. PMID: 24065491 Free article.

9

The role of gender in patients with diffuse large B cell lymphoma treated with rituximab-containing regimens: a meta-analysis.

Yıldırım M, Kaya V, Demirpençe Ö, Paydaş S. Yıldırım M, et al. Arch Med Sci. 2015 Aug 12;11(4):708-14. doi: 10.5114/aoms.2015.53289. Epub 2015 Aug 11. Arch Med Sci. 2015. PMID: 26322081 Free PMC article. Review.

10

Effects of Definitive Chemoradiotherapy on Respiratory Function Tests and Quality of Life Scores During Treatment of Lung Cancer.

Duman E, Yildirim M, Kaya V, Ozturk D, Inal A, Akarsu Z, Gunduz S, Yildiz M. Duman E, et al. Among authors: yildirim m. Asian Pac J Cancer Prev. 2015;16(15):6779-82. doi: 10.7314/apjcp.2015.16.15.6779. Asian Pac J Cancer Prev. 2015. PMID: 26434911 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,317 results

Search Page

Filters